{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T17:54:12Z","timestamp":1793555652597,"version":"4.5.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Anti-platelet factor 4 (PF4) immunothrombosis is characterized by thrombocytopenia, thrombosis and enhanced NETosis and has been described in the absence of prior heparin exposure. This case report describes a patient with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) who, while under immunosuppression, developed anti-PF4-mediated immunothrombosis, with NETosis significantly elevated compared to baseline markers observed during AAV. Treatment with intravenous immunoglobulin (IVIG) led to resolution of the syndrome, marked by a reduction in NETosis markers, restoration of platelet counts, and alleviation of the hypercoagulable state. We review the epidemiology, pathogenesis, clinical manifestations, and management strategies of thrombotic anti-PF4 immune disorders, highlighting the roles of AAV and dysregulated NETosis as key triggers. Early recognition of anti-PF4-mediated immunothrombosis without prior heparin exposure is critical, as prompt treatment with IVIG and direct thrombin inhibitors can significantly improve outcomes. This case underscores the interplay between NETosis, ANCA vasculitis, and thrombotic anti-PF4 immune disorders, emphasizing the therapeutic potential of IVIG in mitigating NETosis-related complications.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1567999","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:10:31Z","timestamp":1744258231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: Anti-platelet factor 4 -mediated immunothrombosis in a patient with ANCA vasculitis \u2013 a shared mechanism of NETosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Lital","family":"Remez-Gabay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Vdovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"Akria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etty","family":"Kruzel-Davila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.315445","article-title":"Heparin-induced thrombocytopenia: A focus on thrombosis","volume":"41","author":"Arepally","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1411910","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J Thromb Haemost"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03040.x","article-title":"Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of \u2018spontaneous\u2019 HIT","volume":"6","author":"Jay","year":"2008","journal-title":"J Thromb Haemost"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2210813","article-title":"Vaccine-induced immune thrombocytopenia and thrombosis after the sputnik V vaccine","volume":"387","author":"Herrera-Comoglio","year":"2022","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.seminhematol.2022.02.005","article-title":"Platelet-activating anti-PF4 disorders: An overview","volume":"59","author":"Warkentin","year":"2022","journal-title":"Semin Hematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-549741","article-title":"Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder","volume":"123","author":"Warkentin","year":"2014","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.03.012","article-title":"A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia","volume":"121","author":"Warkentin","year":"2008","journal-title":"Am J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.thromres.2021.05.018","article-title":"Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia","volume":"204","author":"Warkentin","year":"2021","journal-title":"Thromb Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297920100065","article-title":"NETosis: molecular mechanisms, role in physiology and pathology","volume":"85","author":"Vorobjeva","year":"2020","journal-title":"Biochem (Mosc)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, complement, and coagulation: a triangular relationship","volume":"16","author":"de Bont","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1211601","article-title":"Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus","volume":"92","author":"Parker","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2018.08.014","article-title":"Stimulus-dependent chromatin dynamics, citrullination, calcium signalling and ROS production during NET formation","volume":"1865","author":"de Bont","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1261151","article-title":"The involvement of NETs in ANCA-associated vasculitis","volume":"14","author":"Shiratori-Aso","year":"2023","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","article-title":"Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"Perdomo","year":"2019","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1172\/jci.insight.99445","article-title":"Neutrophil accumulation and NET release contribute to thrombosis in HIT","volume":"3","author":"Gollomp","year":"2018","journal-title":"JCI Insight"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.1038\/s41467-022-32946-1","article-title":"NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia","volume":"13","author":"Leung","year":"2022","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/ijlh.12993","article-title":"Laboratory diagnosis of heparin-induced thrombocytopenia","author":"Warkentin","year":"2019","journal-title":"Int\u00a0J Lab Hematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/jcm9041226","article-title":"Detection of platelet-activating antibodies associated with heparin-induced thrombocytopenia","volume":"9","author":"Tardy","year":"2020","journal-title":"J Clin Med"},{"key":"B21","article-title":"Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations","volume":"136","author":"Rhodes","year":"1973","journal-title":"Surg Gynecol Obstet"},{"key":"B22","article-title":"Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia","volume":"68","author":"Amiral","year":"1992","journal-title":"Thromb Haemost"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280366","article-title":"Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy","volume":"107","author":"Greinacher","year":"2022","journal-title":"Haematologica"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1056\/NEJMc2107227","article-title":"Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"385","author":"Eichinger","year":"2021","journal-title":"Reply. N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ijlh.14075","article-title":"Platelet factor 4 triggers thrombo-inflammation by bridging innate and adaptive immunity","author":"Greinacher","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"100270","DOI":"10.1016\/j.lanepe.2021.100270","article-title":"Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany","volume":"12","author":"Thiele","year":"2022","journal-title":"Lancet regional Health Europe"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"14945","DOI":"10.1038\/ncomms14945","article-title":"Anti-platelet factor 4\/polyanion antibodies mediate a new mechanism of autoimmunity","volume":"8","author":"Nguyen","year":"2017","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4294","article-title":"An emerging role for neutrophil extracellular traps in noninfectious disease","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/vaccines10081267","article-title":"Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects","volume":"10","author":"Hetland","year":"2022","journal-title":"Vaccines"},{"key":"B36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.seminhematol.2022.02.004","article-title":"Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)","volume":"59","author":"Greinacher","year":"2022","journal-title":"Semin Hematol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.123.319522","article-title":"PAD4-induced NETosis via cathepsin G-mediated platelet-neutrophil interaction in chAdOx1 vaccine-induced thrombosis-brief report","volume":"43","author":"Carnevale","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/jcm12196176","article-title":"Different types of vasculitis complicated by heparin-induced thrombocytopenia-analysis of four cases and literature review","volume":"12","author":"Rytel","year":"2023","journal-title":"J Clin Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2724304","DOI":"10.1155\/2019\/2724304","article-title":"A case of heparin-induced thrombocytopenia that developed in the therapeutic course of anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"2019","author":"Nonaka","year":"2019","journal-title":"Case Rep Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sft075","article-title":"Management of heparin-induced thrombocytopenia (HIT) in patients with systemic vasculitis and pulmonary haemorrhage","volume":"6","author":"Thong","year":"2013","journal-title":"Clin Kidney J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-478966","article-title":"Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4","volume":"122","author":"Jaax","year":"2013","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-504126","article-title":"HIT: nucleic acid masquerading as heparin","volume":"122","author":"Chong","year":"2013","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1758818","article-title":"Laboratory testing for heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia antibodies: A narrative review","volume":"49","author":"Warkentin","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2019.1636645","article-title":"High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review","volume":"12","author":"Warkentin","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/17474086.2019.1636645","article-title":"Transforming growth factor-beta-activated kinase 1 is required for human fcgammaRIIIb-induced neutrophil extracellular trap formation","volume":"7","author":"Aleman","year":"2016","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.993720","article-title":"Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin","volume":"13","author":"Masso-Silva","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1567999\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:10:32Z","timestamp":1744258232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1567999\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2025.1567999"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1567999","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"article-number":"1567999"}}